News

May 22, 2020May 22, 2020

Short Film on Woman with Juvenile Arthritis Highlights Awareness Month

News

A new short film called “Joint Effort” traces the journey of Zoe Zeerip, a Michigan woman who was diagnosed with juvenile idiopathic arthritis (JIA) at age 13. “At such ... Read more

May 21, 2020May 21, 2020

Video Games Connect Chronically Ill Children Isolated at Home, Hospital

cystic fibrosis, News, syndicated

Dara Riva always had a rule that her 10-year-old son could play video games only once a week. But then the COVID-19 pandemic struck, and her perspective changed. Riva’s ... Read more

May 15, 2020May 15, 2020

Janssen Seeks FDA Approval for Simponi Aria in JIA Subtypes

News

Janssen has submitted two new applications to the U.S. Food and Drug Administration (FDA) seeking approval for Simponi Aria (golimumab), in combination with methotrexate, for the treatment of polyarticular juvenile ... Read more

May 8, 2020May 8, 2020

Mobile App Helps Young Arthritis Patients Track Symptoms, Connect with Peers

News

Adolescents and young adults with juvenile arthritis now can rate their daily symptoms in a matter of seconds, track their disease over a period of time, and connect with others ... Read more

April 27, 2020April 27, 2020

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

News, syndicated

While there are few silver linings to the cloud created by COVID-19, the pandemic that has killed tens of thousands, hobbled economies worldwide and drove millions to quarantine in ... Read more

April 24, 2020April 24, 2020

Early Treatment Tied to Inactive Disease Within 1 Year, Canadian Registry Shows

News

Early treatment for juvenile idiopathic arthritis (JIA) is likely the reason for most children with JIA taking part in a Canadian patient registry having inactive disease within one year of diagnosis, ... Read more

April 17, 2020April 17, 2020

Interleukin-33 Could Be Biomarker for JIA in Children, Study Indicates

News

Children with juvenile idiopathic arthritis (JIA) have high levels of a pro-inflammatory protein called interleukin-33 (IL-33) in their blood and the fluid around their joints compared to unaffected children, a new study ... Read more

April 10, 2020April 10, 2020

Aristospan, JIA Treatment, Approved for Public Reimbursement in Canada

News

Aristospan (triamcinolone hexacetonide) — a treatment for juvenile idiopathic arthritis (JIA) and similar disorders — has been approved for public reimbursement in Canada, after the completion of price negotiations with ... Read more

April 3, 2020April 3, 2020

Certain Vaccines in Children with Polyarticular JIA Maintain Effectiveness on Orencia, Study Finds

News

Young children with polyarticular juvenile idiopathic arthritis (pJIA) maintained effective vaccination against diphtheria and tetanus even after starting treatment with Orencia (abatecept) for up to two years, according to ... Read more

April 2, 2020April 2, 2020

CHMP Recommends Enbrel Biosimilar Nepexto for Approval in Europe

News

The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Nepexto, a biosimilar of Enbrel (etanercept), for the treatment of various inflammatory disorders including juvenile idiopathic ... Read more

Pin It on Pinterest